Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 93 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

  2. A Study to Evaluate Chemotherapy-Induced Nausea in Breast Cancer Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN, Albert Lea, MN, Mankato, MN

  3. A Study to Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients for T-cell Directed Immunotherapy

    Jacksonville, FL

  4. A Study to Evaluate the Immune Response to Anti-HER2 Therapies

    Jacksonville, FL

  5. A Study of Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Patient Outcomes after Hepatic Artery Infusion Pump Placement

    Rochester, MN

  7. Fertility Outcomes in Lymphoma Patients

    Jacksonville, FL

  8. Stress Echo 2030

    Rochester, MN

  9. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker

    Jacksonville, FL

  10. A Study of the Use of Cold Caps to Prevent Hair Loss in Chemotherapy Patients

    Rochester, MN

.

Mayo Clinic Footer